Phase 2
Completed N=68
A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)
Source: ClinicalTrials.gov NCT00824616 ↗Enrolled (actual)
68
Serious AEs
2.9%
Results posted
Aug 2012
Primary outcomePrimary: Change From Baseline in Hemoglobin A1c (HbA1c) Level — -0.15; -0.26 % HbA1c — p=0.745
Summary
The purpose of this study is to test the effect MK-0941 as add-on therapy for adults taking insulin for Type 2 Diabetes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline in Hemoglobin A1c (HbA1c) Level |
-0.15; -0.26 | 0.745 |
| PRIMARY Number of Participants Who Experienced One or More Episodes of Hypoglycemia (Symptomatic or Asymptomatic) |
6; 8 | 0.537 |
Eligibility Criteria
Inclusion Criteria
- Participant has Type 2 Diabetes Mellitus
Exclusion Criteria
- Participant has a history of Type 1 Diabetes Mellitus or ketoacidosis
- Participant is on a weight loss program and is not in the maintenance phase or is taking a weight loss medication
- Participant has had surgery within 30 days of starting the study or has planned major surgery
Data sourced from ClinicalTrials.gov (NCT00824616). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.